PubMed COVID-19 Clinical Care

The COVID-19 pandemic has led to an unprecedented shift of consumption from services to goods. We study this demand reallocation in a multi-sector model featuring sticky prices, input-output linkages, and labor reallocation costs. Reallocation costs

CONCLUSIONS: More than half, half, and less than half of the participants, respectively, had knowledge, attitude, and practice of COVID19 in Dessie town.

CONCLUSION: The results of this study suggest a link between COVID-19 and neck pain. Therefore, it is recommended that healthcare service providers are prepared to manage the increased incidence of neck pain among patients who have recovered from

CONCLUSIONS: The present study reveals that COVID-19 infection is commonly associated with mild increased liver enzymes. However, the likelihood of developing acute liver injury was found to be higher in patients with an inflammatory state indicated

CONCLUSIONS: More than half, half, and less than half of the participants, respectively, had knowledge, attitude, and practice of COVID19 in Dessie town.

"Long COVID" is a sustained symptom following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to recent statistics, at least 65 million people have long COVID, which poses a long-term threat to human health. The

CONCLUSION: Older adults who present to primary care with symptoms suggestive of cancer may accept diagnostic testing solely for the benefit of knowing the diagnosis. There was a clear patient preference that referrals and investigations for cancer

A novel coronavirus now known as SARS-CoV-2 emerged during late 2019, possibly following zoonotic crossover from a coronavirus present in bats. This virus was identified as the pathogen responsible for the severe respiratory disease, coronavirus

CONCLUSION: It appears feasible to offer a 10-week exercise programme to patients attending a national cancer centre, with adequate recruitment, retention and adherence rates and high acceptability among stakeholders. CONTRIBUTION OF THE PAPER.

CONCLUSION: We found that 8 of the 30 drugs identified by graph-based scoring on complemented networks as potential candidates for COVID-19 repurposing were additionally supported by real-world patient data in follow-up analyses. These results show